tiprankstipranks
Korro Bio (KRRO)
NASDAQ:KRRO
US Market

Korro Bio (KRRO) Financial Statements

374 Followers

Korro Bio Financial Overview

Korro Bio's market cap is currently ―. The company's EPS TTM is $-38.136; its P/E ratio is -1.27; Korro Bio is scheduled to report earnings on August 8, 2024, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Dec 23Sep 23Jun 23Mar 23
Income Statement-
Total Revenue-$ -1.77M$ 580.00K$ 593.00K$ 593.00K
Gross Profit-$ -1.77M$ 580.00K$ 593.00K$ 593.00K
EBIT$ -19.54M$ -39.50M$ -11.62M$ -10.79M$ -19.23M
EBITDA$ -18.81M$ -37.83M$ -11.24M$ -10.30M$ -18.23M
Net Income Common Stockholders$ -19.56M$ -39.22M$ -11.61M$ -10.80M$ -19.54M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 138.80M$ 166.15M$ 41.72M$ 46.48M$ 66.65M
Total Assets$ 197.99M$ 221.66M$ 46.35M$ 79.38M$ 101.50M
Total Debt$ 35.92M$ 33.21M$ 1.43M$ 27.81M$ 39.97M
Net Debt$ -102.89M$ -132.94M$ -40.30M$ -18.67M$ -26.68M
Total Liabilities$ 46.63M$ 51.75M$ 9.61M$ 33.98M$ 48.25M
Stockholders Equity$ 151.36M$ 169.91M$ 36.74M$ 45.41M$ 53.25M
Cash Flow-
Free Cash Flow$ -27.50M$ -47.66M$ -4.80M$ -8.42M$ -14.23M
Operating Cash Flow$ -21.89M$ -39.92M$ -4.80M$ -8.42M$ -14.13M
Investing Cash Flow$ -5.61M$ -20.36M$ 6.82M$ 19.21M$ 5.50M
Financing Cash Flow$ 139.00K$ 201.89M$ 2.00K$ -11.67M$ -2.47M
Currency in USD

Korro Bio Earnings and Revenue History

Korro Bio Debt to Assets

Korro Bio Cash Flow

Korro Bio Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis